West Virginia University Logo

News

Showing items through of articles.
  • DeLynn Lecture to feature researcher behind breast cancer drug Herceptin

    Wednesday, September 7, 2016

    Dennis Slamon, M.D., Ph.D., an internationally renowned physician scientist whose work led to the development of the breast cancer drug Herceptin, will deliver the 2016 Laurence and Jean DeLynn Lecture at 4 p.m., September 7, in the Fukushima Auditorium of the of the West Virginia University Health Sciences Center. A reception will follow in the Learning Center Commons.

  • Cancer Institute summer research fellows to present research

    Wednesday, August 3, 2016

     Pictured:(l-r) Joseph McGuire, Cassidy Bland, River Hames, Patrick Thomas and Eric Lundstrom

  • Otolaryngology resident's research work honored

    Thursday, July 28, 2016

    Phillip “Alex” Montague, M.D., WVU Medicine Department of Otolaryngology resident with WVU Cancer Institute ties, has been recognized for his outstanding research presentation.  During the Department of Otolaryngology’s annual alumni conference, Dr. Montague received the Sobisca S. Hall Award for his research project entitled Invasion in Head and Neck Cancer.

  • Cancer Institute provides continuing education on breast cancer

    Tuesday, July 19, 2016

    Nearly 200 healthcare professionals from Morgantown and the surrounding region took advantage of the 2nd Annual WVU Cancer Institute Breast Cancer Conference: From Mammograms to Metastatic Breast Cancer held recently at Erickson Alumni Center in Morgantown.  Several who attended the continuing education event were from the Cancer Institute’s regional affiliates at Berkeley Medical Center in Martinsburg, Camden Clark Medical Center in Parkersburg and Garrett Regional Medical Center in Oakland, MD.  Bonnie’s Bus Director Sara Jane Gainor and WVU Cancer Institute Director of Clinical Services Hannah Hazard, MD, shared various aspects of the conference with WBOY TV.

  • Cancer Institute announces winners of the 2015 Awards of Excellence

    Friday, July 1, 2016

    The Cancer Institute congratulates the winners of the 2015 Awards of Excellence! The awards go to WVU faculty members and employees of the Cancer Institute who are selected by their peers for distinct recognition of exceptional performance in one of several categories including:

  • Clinical Trials Extend Beyond Treatment: Faith-Based Project Helps Appalachians Get Healthier

    Monday, May 16, 2016

    The WVU Cancer Institute’s Cancer Prevention and Control participated in a prevention trial last year with the Appalachia Community Cancer Network (ACCN) to promote health and raise awareness about cancer prevention and early detection across the Appalachian Region.

  • The Defense Health Program: DoD Peer Reviewed Medical Research Programs

    Friday, May 6, 2016

    The Fiscal Year 2016 (FY16) Defense Appropriations Act provides $278.7 million to the Department of Defense Peer Reviewed Medical Research Program (PRMRP).  The vision of the PRMRP is to improve the health and well-being of all military Service members, Veterans, and beneficiaries.  The PRMRP challenges the scientific and clinical communities to address one of the FY16 congressionally directed topic areas with original ideas that foster new directions in basic science and translational research; novel product development leading to improved therapeutic or diagnostic tools; synergistic, multidisciplinary research programs; or clinical trials that address an immediate clinical need.

  • Traineeship Positions available in the Behavioral and Biomedical Sciences

    Tuesday, May 3, 2016

    The WVU Behavioral and Biomedical Sciences (BBS) Research Training Program, supported by NIGMS grant T32 GM081741, is now accepting applications for trainees for the 2016-2017 academic year.

  • WVU researcher receives $1.7 million award to fight cancer

    Wednesday, April 20, 2016

    A West Virginia University researcher has been awarded $1.7 million to conduct research into how immunotherapy can strengthen the body’s own defenses to improve treatment for breast and lung cancers.